Our Current Studies
Antibiotic resistant infections are one of today’s most pressing health threats.
Learn more about our work to develop new paths for combating antibiotic resistance and improving healthcare practices to avoid the spread of MRSA (methicillin resistant Staphylococcus aureus) and other highly antibiotic-resistant bacteria.
CORGI Trial
Join a trial that aims to find new treatment options for bone and joint infections, particularly focusing on omadacycline to assess its safety, effectiveness, and tolerability in treating antibiotic-resistant germs causing these infections. This study is enrolling adults with current bone and joint infection.
TODOS Trial
Join a trial that aims compare the efficacy and safety of doxycycline and trimethoprim/sulfamethoxazole in treating skin infections. This study is enrolling adults with current skin infections.
Contact Us
Reach out to our team for more information on our current and upcoming studies.
Email us at IDCORE@Lundquist.org
© 2023 ID CORE at The Lundquist Institute For Biomedical Innovation at Harbor-UCLA Medical Center